- Report
- May 2025
- 100 Pages
Global
From €2467EUR$2,789USD£2,101GBP
- Report
- January 2025
- 180 Pages
Global
From €3384EUR$3,825USD£2,882GBP
€3981EUR$4,500USD£3,390GBP
- Report
- August 2022
- 82 Pages
Global
From €3092EUR$3,495USD£2,633GBP
- Report
- December 2023
- 180 Pages
Global
From €2212EUR$2,500USD£1,883GBP
- Report
- May 2022
- 243 Pages
Global
From €2212EUR$2,500USD£1,883GBP
The Fungal Infection Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases caused by bacteria, viruses, fungi, and parasites. Fungal Infection Drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common fungal infections include athlete's foot, ringworm, and yeast infections.
Fungal Infection Drugs are available in a variety of forms, including tablets, capsules, creams, and ointments. These drugs are typically prescribed by a doctor and can be purchased over-the-counter or online.
Some companies in the Fungal Infection Drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Bayer. Show Less Read more
